Sintx Technologies (SINT) Liabilities and Shareholders Equity (2013 - 2026)
Sintx Technologies (SINT) posted quarterly Liabilities and Shareholders Equity of $7.8 million for Q1 2026, down 31.78% year-over-year from $11.4 million in Q1 2025, and down 17.83% quarter-over-quarter from $9.5 million in Q4 2025.
Sintx Technologies (SINT) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
Sintx Technologies' Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 31.78% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $37.9 million (down 20.2% YoY), while the FY2025 annual figure was $9.5 million, up 0.99% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $7.8 million, down from $9.5 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $22.7 million in Q1 2023, with the low at $7.8 million in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $15.3 million (2024), against an average of $14.2 million.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity slumped 41.44% in 2022, then rose 19.95% in 2023.
- Sintx Technologies' Liabilities and Shareholders Equity stood at $15.8 million in 2022, then decreased by 2.59% to $15.4 million in 2023, then slumped by 38.74% to $9.4 million in 2024, then grew by 0.99% to $9.5 million in 2025, then fell by 17.83% to $7.8 million in 2026.
- Business Quant data shows SINT's Liabilities and Shareholders Equity at $7.8 million in Q1 2026, $9.5 million in Q4 2025, and $11.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Sintx Technologies | 7.53 Mn | 7.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.81 Mn |
| Dec 31, 2025 | 9.51 Mn |
| Sep 30, 2025 | 11.36 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 11.45 Mn |
| Dec 31, 2024 | 9.41 Mn |
| Sep 30, 2024 | 11.30 Mn |
| Jun 30, 2024 | 15.30 Mn |
| Mar 31, 2024 | 17.56 Mn |
| Dec 31, 2023 | 15.37 Mn |
| Sep 30, 2023 | 15.51 Mn |
| Jun 30, 2023 | 19.10 Mn |
| Mar 31, 2023 | 22.65 Mn |
| Dec 31, 2022 | 15.77 Mn |
| Sep 30, 2022 | 14.56 Mn |
| Jun 30, 2022 | 17.49 Mn |
| Mar 31, 2022 | 18.88 Mn |
| Dec 31, 2021 | 21.84 Mn |
| Sep 30, 2021 | 24.87 Mn |
| Jun 30, 2021 | 26.42 Mn |